Stocks and Investing Stocks and Investing
Tue, March 5, 2024

Morten Herholdt Maintained (BLUE) at Sell with Decreased Target to $1.02 on, Mar 5th, 2024


Published on 2024-10-28 09:26:52 - WOPRAI, Morten Herholdt
  Print publication without navigation


Morten Herholdt of HSBC, Maintained "bluebird bio, Inc." (BLUE) at Sell with Decreased Target from $2.31 to $1.02 on, Mar 5th, 2024.

Morten has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 2 agree with Morten's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $5 on, Friday, December 15th, 2023
  • Jeffrey Hung of "Morgan Stanley" Upgraded from Sell to Hold and Increased Target to $7 on, Friday, December 8th, 2023


These are the ratings of the 3 analyists that currently disagree with Morten


  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $5 on, Thursday, December 21st, 2023
  • Jack Allen of "Baird" Maintained at Buy with Decreased Target to $7 on, Tuesday, December 12th, 2023
  • Dane Leone of "Raymond James" Maintained at Buy with Increased Target to $13 on, Wednesday, November 8th, 2023
Contributing Sources